Huang, Y., Liu, Y., He, H., Li, Z., Lin, N., Bai, O., Li, C., Wang, X., Li, Y., Zhao, X., Wu, H., Fu, X., Yao, Z., Zhang, J., Chen, Y., Meng, W., Wu, Z., Tian, W., Song, Y. (2025). Phase I/Ⅱ study evaluating the safety and preliminary efficacy of amulirafusp alfa (IMM0306) in combination with lenalidomide in patients with relapsed/refractory CD20-positive follicular lymphoma. Blood. https://doi.org/10.1182/blood-2025-5358